Avalon Ventures
Script error: No such module "AfC submission catcheck".
| Private Ownership | |
| ISIN | 🆔 |
| Industry | Venture capital |
| Founded 📆 | 1983 |
| Founder 👔 | |
| Headquarters 🏙️ | La Jolla, California, U.S. |
Area served 🗺️ | |
| Products 📟 | Venture capital, Growth capital |
| Total assets | 11,919 homepage = www.avalon-ventures.com |
| Members | |
Number of employees | 1-10 |
| 🌐 Website | [Lua error in Module:WikidataIB at line 665: attempt to index field 'wikibase' (a nil value). ] |
| 📇 Address | |
| 📞 telephone | |
Avalon Ventures is an American venture capital firm that has founded and/or funded more than 127 information technology and life sciences companies. Created in 1983 by Kevin Kinsella, the company has offices in La Jolla, California and Cambridge, Massachusetts.[1]
In September 2019, GSK announced it would acquire Sitari Pharmaceuticals and its transglutaminase 2 (TG2) small molecule program for the treatment of celiac disease.[2][3]
References[edit]
- ↑ "Avalon Ventures - Wiki". Golden. Retrieved 2023-06-20.
- ↑ "GSK to Acquire Celiac-Focused Sitari Pharmaceuticals". BioSpace.
- ↑ Inc, COI Pharmaceuticals. "Avalon Ventures Expands Collaboration with GSK and Launches Seventh New Company at COI Pharmaceuticals". www.prnewswire.com (Press release). Retrieved 2023-06-20.
This article "Avalon Ventures" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Avalon Ventures. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
